We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $5.69B
1-Year Est. Return 60.64%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+60.64%
3 Year Est. Return
+143.93%
5 Year Est. Return
+204.18%
10 Year Est. Return
+832.04%
AUM
$5.69B
AUM Growth
+$717M
Cap. Flow
+$39.1M
Cap. Flow %
0.69%
Top 10 Hldgs %
7.69%
Holding
1,326
New
105
Increased
437
Reduced
332
Closed
93

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$27.3M
2
DHT icon
DHT Holdings
DHT
+$21.2M
3
VVX icon
V2X
VVX
+$19M
4
SDRL icon
Seadrill
SDRL
+$13.2M
5
VSAT icon
Viasat
VSAT
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 28.79%
2 Consumer Discretionary 13.92%
3 Technology 13.18%
4 Industrials 10.69%
5 Energy 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATY icon
601
Cathay General Bancorp
CATY
$4.13B
$1.8M 0.03%
29,000
PTCT icon
602
PTC Therapeutics
PTCT
$5.74B
$1.79M 0.03%
22,000
EML icon
603
Eastern Company
EML
$157M
$1.77M 0.03%
63,501
TCBI icon
604
Texas Capital Bancshares
TCBI
$4.25B
$1.76M 0.03%
+17,000
New +$1.71M
GCT icon
605
GigaCloud Technology
GCT
$1.86B
$1.74M 0.03%
55,000
OVLY icon
606
Oak Valley Bancorp
OVLY
$288M
$1.73M 0.03%
51,279
-5,000
-9% -$168K
ALL icon
607
Allstate
ALL
$64.1B
$1.73M 0.03%
+7,250
New +$1.58M
FNKO icon
608
Funko
FNKO
$318M
$1.72M 0.03%
293,238
-152,251
-34% -$732K
PBI icon
609
Pitney Bowes
PBI
$2.33B
$1.72M 0.03%
+98,273
New +$1.5M
ONT
610
Onterris Inc
ONT
$629M
$1.72M 0.03%
+85,054
New +$1.59M
SGMT icon
611
Sagimet Biosciences
SGMT
$666M
$1.71M 0.03%
221,541
-78,100
-26% -$531K
IBKR icon
612
Interactive Brokers
IBKR
$41.2B
$1.71M 0.03%
19,600
-7,300
-27% -$608K
CLYM
613
Climb Bio
CLYM
$913M
$1.7M 0.03%
130,300
-4,000
-3% -$41.3K
WLY icon
614
John Wiley & Sons Class A
WLY
$2.47B
$1.7M 0.03%
+35,000
New +$1.47M
ALNT icon
615
Allient
ALNT
$1.63B
$1.68M 0.03%
16,300
NUS icon
616
Nu Skin
NUS
$231M
$1.67M 0.03%
317,074
-142,858
-31% -$913K
DHX icon
617
DHI Group
DHX
$187M
$1.66M 0.03%
448,187
+5,192
+1% +$17.1K
BNL icon
618
Broadstone Net Lease
BNL
$4.02B
$1.65M 0.03%
80,000
REAL icon
619
The RealReal
REAL
$1.19B
$1.65M 0.03%
+140,000
New +$1.49M
CHCO icon
620
City Holding Co
CHCO
$2.03B
$1.64M 0.03%
12,392
MNSB icon
621
MainStreet Bancshares
MNSB
$182M
$1.64M 0.03%
66,551
+2,775
+4% +$65.3K
IRWD icon
622
Ironwood Pharmaceuticals
IRWD
$689M
$1.64M 0.03%
389,793
-50,700
-12% -$195K
AIT icon
623
Applied Industrial Technologies
AIT
$12B
$1.64M 0.03%
+4,840
New +$1.48M
METC icon
624
Ramaco Resources Class A
METC
$794M
$1.63M 0.03%
122,998
NYT icon
625
New York Times
NYT
$11B
$1.62M 0.03%
23,200

Similar funds

Bridgeway Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Bridgeway Capital Management held 1,326 positions worth $5.69B, up 14% from $4.97B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Bridgeway Capital Management's Q2 2026 filing shows 105 new, 437 increased, 332 reduced and 93 closed positions. Its largest new stake was PagSeguro Digital: 1,364,381 shares worth $12.3M. The largest sale was Advanced Micro Devices, an estimated $27.3M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q2 2026 buy was PagSeguro Digital: 1,364,381 shares worth $12.3M.
  • Bridgeway Capital Management added most to Vistance Networks Inc in Q2 2026, an estimated $17.7M increase.
  • Bridgeway Capital Management's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $27.3M.
  • Bridgeway Capital Management fully exited DHT Holdings in Q2 2026, selling an estimated $21.2M.
  • Bridgeway Capital Management's ten largest holdings make up 7.7% of its $5.69B portfolio in Q2 2026.
  • Bridgeway Capital Management opened 105 new positions and closed 93 in Q2 2026.
  • Bridgeway Capital Management's portfolio value rose 14% quarter-over-quarter to $5.69B.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.